These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7609532)

  • 21. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
    Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
    Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia and thrombosis.
    Patel VP; Bong M; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis.
    Martin U; Dörge L; Fischer S
    Br J Pharmacol; 1996 May; 118(2):271-6. PubMed ID: 8735626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early onset of heparin-induced thrombocytopenia with thrombosis after open heart surgery: importance of an early diagnosis and Lepirudin treatment.
    Paparella D; Galeone A; Micelli M; Memmola C; de Luca Tupputi Schinosa L
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):183-5. PubMed ID: 15091006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repetitive intraoperative use of recombinant hirudin (Lepirudin) in peripheral vascular surgery with HITT.
    Goti F; Korte W; Sege D
    Swiss Med Wkly; 2001 Dec; 131(47-48):693-4. PubMed ID: 11875754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with lepirudin in heparin-induced thrombocytopenia. A case report].
    Nippert M; de Maistre E; Rodermann M; Vançon AC; Amrein D; Brembilla-Perrot B; Lecompte T; Zannad F; Aliot E
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1234-8. PubMed ID: 12611047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of hirudin therapy with the Thrombelastograph.
    Pivalizza EG
    J Clin Anesth; 2002 Sep; 14(6):456-8. PubMed ID: 12393117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT).
    Jy W; Mao WW; Horstman LL; Valant PA; Ahn YS
    Thromb Haemost; 1999 Oct; 82(4):1255-9. PubMed ID: 10544909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 36. Bilateral renal artery thrombosis due to heparin-induced thrombocytopenia-thrombosis syndrome. Successful treatment with longterm application of lepirudin.
    Tsirigotis P; Mantzios G; Makris F; Robos Y
    Ulster Med J; 2006 Jan; 75(1):88-90. PubMed ID: 16457411
    [No Abstract]   [Full Text] [Related]  

  • 37. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjunctive therapies in the cath lab. Use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia.
    Caputo RP; Giambartolomei A; Simons A; Reger M; Wagner S; Esente P
    J Invasive Cardiol; 2001 Sep; 13(9):657-60. PubMed ID: 11533507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia with thromboembolic arterial occlusion treated with recombinant hirudin.
    Schmidt OH; Lang W
    N Engl J Med; 1997 Nov; 337(19):1389. PubMed ID: 9380091
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heparin-induced thrombocytopenia type II].
    Breuer HW; Müller R; Greinacher A
    Dtsch Med Wochenschr; 1999 Jan; 124(3):67. PubMed ID: 9987492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.